Scientists of the Ural Federal University (URFU) found that aspirin can be useful in treating COVID-19. It turned out that the antipyretic potentially reduces the activity of the coronavirus SARS-COV-2 by binding to several viral proteins. This is reported in a press release available on the Soluki.rf website.
Researchers used the molecular dock method – modeling the structure of the molecule when binding to the active centers of another molecule. It turned out that aspirin effectively interacts with several coronavirus protein molecules and, possibly, suppresses the activity of viral particles.
Experts also compared the binding energy arising between the drugs and proteins of the virus, among various drugs, including aspirin, Repessivir and Favipevir. The antipyretic demonstrated higher energy values compared to Favipevir. At the same time, Remidesivir was the most effective.
The authors of the work hope that the results will help develop new drugs against COVID-19, allowing you to appreciate what active substances are effectively associated with coronavirus.